Literature DB >> 10403681

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product.

S Usuda1, H Okamoto, H Iwanari, K Baba, F Tsuda, Y Miyakawa, M Mayumi.   

Abstract

An ELISA was developed for serological determination of the six genotypes of hepatitis B virus (HBV) designated A, B, C, D, E, and F. Monoclonal antibodies were raised against genotype-specific epitopes in the preS2-region product, and labeled with horseradish peroxidase. Hepatitis B surface antigen (HBsAg) in sera was captured by immobilized antibodies against the common determinant, and evaluated for reactivity with genotype-specific monoclonal antibodies labeled with the enzyme. Serological genotyping was in complete accord with genotypes determined by S-gene sequences in a panel of 68 sera containing HBV/HBsAg of different genotypes. Of 514 sera with HBsAg from Japan, 507 (98.6%) were genotyped serologically: genotype A was identified in 24 (4.7%); B in 196 (38.1%); C in 282 (54.9%); D in 2 (0.4%); and F in 3 (0.6%). There were no sera containing HBV of genotype E. Likewise, 425 of 446 (95.3%) sera with HBsAg from Brazil, China, India, Indonesia, Kenya, Korea, Nepal, Papua New Guinea, the Philippines, and Thailand were classified into A (25.6%), B (24.2%), C (33.9%), and D (11.7%) genotypes; there were no sera with HBsAg of genotype E or F among them. Some sera unclassifiable by ELISA revealed mixed infection with HBV of distinct genotypes, or contained HBsAg deprived of genotype-specific epitopes by point mutations. The ELISA would be useful for large-scale surveys, because it allows serological detection of HBV genotypes without sequencing nucleotides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403681     DOI: 10.1016/s0166-0934(99)00039-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  59 in total

1.  Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit.

Authors:  Takashi Moriya; Isamu K Kuramoto; Hiroshi Yoshizawa; Paul V Holland
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.

Authors:  Shu-Fen Liu; Meng-Hsuan Hsieh; Nai-Jen Hou; Ming-Yen Hsieh; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2010-08-03       Impact factor: 6.047

3.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

4.  Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level.

Authors:  Tomoko Kurihara; Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Tatsuo Kanda; Shigenobu Kawai; Hiromitsu Saisho
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

Review 5.  Update of research and management of hepatitis B.

Authors:  Takeshi Okanoue; Masahito Minami
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life.

Authors:  Tatsuji Maeshiro; Shingo Arakaki; Takako Watanabe; Hajime Aoyama; Joji Shiroma; Tsuyoshi Yamashiro; Tetsuo Hirata; Akira Hokama; Fukunori Kinjo; Tomofumi Nakayoshi; Tomokuni Nakayoshi; Masashi Mizokami; Jiro Fujita; Hiroshi Sakugawa
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

7.  Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.

Authors:  Hideaki Kato; Kei Fujiwara; Robert G Gish; Hiroshi Sakugawa; Hiroshi Yoshizawa; Fuminaka Sugauchi; Etsuro Orito; Ryuzo Ueda; Yasuhito Tanaka; Takanobu Kato; Yuzo Miyakawa; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

8.  Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.

Authors:  Fumitaka Suzuki; Yoshiyuki Suzuki; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Shunichiro Fujiyama; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Rie Mineta; Yukiko Suzuki; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2016-10-03       Impact factor: 7.527

9.  Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.

Authors:  Kentaro Matsuura; Yasuhito Tanaka; Shuhei Hige; Gotaro Yamada; Yoshikazu Murawaki; Masafumi Komatsu; Tomoyuki Kuramitsu; Sumio Kawata; Eiji Tanaka; Namiki Izumi; Chiaki Okuse; Shinichi Kakumu; Takeshi Okanoue; Keisuke Hino; Yoichi Hiasa; Michio Sata; Tatsuji Maeshiro; Fuminaka Sugauchi; Shunsuke Nojiri; Takashi Joh; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

10.  Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii.

Authors:  Mayumi Sakurai; Fuminaka Sugauchi; Naoky Tsai; Seiji Suzuki; Izumi Hasegawa; Kei Fujiwara; Etsuro Orito; Ryuzo Ueda; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.